2020-03-02 最新期刊文獻

-
本日新增40篇文獻。臺灣皮膚科醫學會特別在Dermatologica Sinica中表示，確診患者服用的藥物，已知會誘發全身性的藥疹，因此在臨床治療時的鑑別診斷格外重要。而這段期間內，醫護人員的職業性皮膚病病例也正在增加，皮膚科醫生更需要孰悉治療以及進行預防(21)。
隨著COVID-19的研究文獻越來越多，JAMA(10)、BMC Medicine(12)、Nature Medicine(28)、Journal of Medical Virology(31)就目前文獻研究將臨床病徵、致死率、快篩方式、治療及感控做了整理(10)。大陸流行病學專家鍾南山研究團隊在NEJM的文獻示警，統計發現，入院時沒發燒的患者竟超過5成，因此若檢測只放在是否發燒，可能會出現防疫漏洞(16，相關新聞)。
在診斷上，COVID-19在胸部CT影像上有明確診斷特徵，華中科大就武漢81例病例的CT影像進行分析，並推論高齡、男性和合併症是病患預後不良的危險因素(30)，包括廣東(36)、香港(22)都有相關研究報告。
另外在防疫策略上，美國國安會專家認為重點須從邊境防疫轉為緩解社區感染，許多流行病學專家及世衛組織也不認可旅行禁令的效果，但部分公衛專家仍堅持邊境防疫的重要性(9)。另中國基於防疫考量，武漢和湖北等流行地區從2月10日開始，針對捐血者血液進行病毒篩檢，由於血清或淋巴細胞中也可監測到病毒，因此血液中心和相關實驗室也需加強安全保護措施(4,26)。

  1. Ahmed SF, Quadeer AA & McKay MR. (2020). Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.  Viruses, 12, doi:10.3390/v12030254, https://doi.org/10.3390/v12030254 
  2. (2020). Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.  BMJ, 368, m792. doi:10.1136/bmj.m792, https://doi.org/10.1136/bmj.m792 
  3. Bhattacharya M, Ranjan Sharma A, Patra P, Ghosh P, Sharma G, Chandra Patra B, et al. (2020). Development of epitope-based peptide vaccine against novel Coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.  Journal of Medical Virology, doi:10.1002/jmv.25736, https://doi.org/10.1002/jmv.25736 
  4. Chang L, Yan Y & Wang L. (2020). Coronavirus Disease 2019: Coronaviruses and Blood Safety.  Transfusion Medicine Reviews, doi:10.1016/j.tmrv.2020.02.003, https://doi.org/10.1016/j.tmrv.2020.02.003 
  5. Chen S, Yang J, Yang W, Wang C & Barnighausen T. (2020). COVID-19 control in China during mass population movements at New Year.  Lancet, doi:10.1016/S0140-6736(20)30421-9, https://doi.org/10.1016/S0140-6736(20)30421-9 
  6. Cheng VCC, Wong SC, To KKW, Ho PL & Yuen KY. (2020). Preparedness and proactive infection control measures against the emerging novel coronavirus in China.  Journal of Hospital Infection, doi:10.1016/j.jhin.2020.01.010, https://doi.org/10.1016/j.jhin.2020.01.010 
  7. Cheung JC, Ho LT, Cheng JV, Cham EYK & Lam KN. (2020). Staff safety during emergency airway management for COVID-19 in Hong Kong.  The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(20)30084-9, https://doi.org/10.1016/S2213-2600(20)30084-9 
  8. Cleemput S, Dumon W, Fonseca V, Karim WA, Giovanetti M, Alcantara LC, et al. (2020). Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes.  Bioinformatics, doi:10.1093/bioinformatics/btaa145, https://doi.org/10.1093/bioinformatics/btaa145 
  9. Cohen J & Kupferschmidt K. (2020). Strategies shift as coronavirus pandemic looms.  Science, 367, 962-963. doi:10.1126/science.367.6481.962, https://doi.org/10.1126/science.367.6481.962 
  10. Del Rio C & Malani PN. (2020). COVID-19-New Insights on a Rapidly Changing Epidemic.  JAMA, doi:10.1001/jama.2020.3072, https://doi.org/10.1001/jama.2020.3072 
  11. Fauci AS, Lane HC & Redfield RR. (2020). Covid-19 - Navigating the Uncharted.  New England Journal of Medicine, doi:10.1056/NEJMe2002387, https://doi.org/10.1056/NEJMe2002387 
  12. Fisher D & Heymann D. (2020). Q&A: The novel coronavirus outbreak causing COVID-19.  BMC Medicine, 18, 57. doi:10.1186/s12916-020-01533-w, https://doi.org/10.1186/s12916-020-01533-w 
  13. Gates B. (2020). Responding to Covid-19 - A Once-in-a-Century Pandemic?.  New England Journal of Medicine, doi:10.1056/NEJMp2003762, https://doi.org/10.1056/NEJMp2003762 
  14. Ghebreyesus TA & Swaminathan S. (2020). Scientists are sprinting to outpace the novel coronavirus.  Lancet, doi:10.1016/S0140-6736(20)30420-7, https://doi.org/10.1016/S0140-6736(20)30420-7 
  15. Gou SM, Yin T, Xiong JX, Peng T, Li Y & Wu HS. (2020).新型冠狀病毒肺炎疫情下胰腺外科患者診療及感染防控策略探討 [Treatment of pancreatic diseases and prevention of infection during outbreak of 2019 coronavirus disease].  Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery], 58, E006. doi:10.3760/cma.j.cn112139-20200224-00123, https://doi.org/10.3760/cma.j.cn112139-20200224-00123 
  16. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China.  New England Journal of Medicine, doi:10.1056/NEJMoa2002032, https://doi.org/10.1056/NEJMoa2002032 
  17. Hosseiny M, Kooraki S, Gholamrezanezhad A, Reddy S & Myers L. (2020). Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome.  AJR. American Journal of Roentgenology, 1-5. doi:10.2214/AJR.20.22969, https://doi.org/10.2214/AJR.20.22969 (需訂閱)
  18. Jernigan DB & CDC COVID-19 Response Team. (2020). Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.  MMWR - Morbidity & Mortality Weekly Report, 69, 216-219. doi:10.15585/mmwr.mm6908e1, https://doi.org/10.15585/mmwr.mm6908e1 
  19. Kanne JP, Little BP, Chung JH, Elicker BM & Ketai LH. (2020). Essentials for Radiologists on COVID-19: An Update-Radiology Scientific Expert Panel.  Radiology, 200527. doi:10.1148/radiol.2020200527, https://doi.org/10.1148/radiol.2020200527 
  20. Koh D. (2020). Occupational risks for COVID-19.  Occupational Medicine (Oxford), doi:10.1093/occmed/kqaa036, https://doi.org/10.1093/occmed/kqaa036 
  21. Lee CH. (2020). Role of dermatologists in the uprising of the novel corona virus (COVID-19): Perspectives and opportunities. Dermatol Sin [serial online] 2020;38:1-2, doi:10.4103/ds.ds_5_20, http://www.dermsinica.org/text.asp?2020/38/1/1/279607
  22. Lee EYP, Ng MY & Khong PL. (2020). COVID-19 pneumonia: what has CT taught us?.  The Lancet Infectious Diseases, doi:10.1016/S1473-3099(20)30134-1, https://doi.org/10.1016/S1473-3099(20)30134-1 
  23. Li LH, Zhang G, Dang XW & Li L. (2020). 新型冠狀病毒疫情期間巴德-吉亞利綜合徵患者的治療策略 [Treatment strategies of Budd-Chiari syndrome during the epidemic period of 2019 coronavirus disease].  Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery], 58, E007. doi:10.3760/cma.j.cn112139-20200221-00109, https://doi.org/10.3760/cma.j.cn112139-20200221-00109 
  24. Lin SM, Lin SC, Hsu JN, Chang CK, Chien CM, Wang YS, et al. (2020). Structure-based stabilization of non-native protein-protein interactions of coronavirus nucleocapsid proteins in antiviral drug design.  Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.9b01913, https://doi.org/10.1021/acs.jmedchem.9b01913 
  25. Liu M, Xu HL, Yuan M, Liu ZR, Wu XY, Zhang Y, et al. (2020). 安徽省新型冠狀病毒肺炎流行與疫情時空變化分析 [Analysis on epidemic situation and spatiotemporal changes of COVID-19 in Anhui].  Chung-Hua Yu Fang i Hsueh Tsa Chih [Chinese Journal of Preventive Medicine], 54, E019. doi:10.3760/cma.j.cn112150-20200221-00150, https://doi.org/10.3760/cma.j.cn112150-20200221-00150 
  26. Liu XM & Wang DQ. (2020). 新型冠狀病毒肺炎疫情下輸血科工作開展的建議與思考 [Consideration and suggestions on development of blood transfusion department under the epidemic situation of novel coronavirus pneumonia].  Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal], 100, E013. doi:10.3760/cma.j.cn112137-20200221-00387, https://doi.org/10.3760/cma.j.cn112137-20200221-00387 
  27. Pan Y, Zhang D, Yang P, Poon LLM & Wang Q. (2020). Viral load of SARS-CoV-2 in clinical samples.  The Lancet Infectious Diseases, doi:10.1016/S1473-3099(20)30113-4, https://doi.org/10.1016/S1473-3099(20)30113-4 
  28. Poon LLM & Peiris M. (2020). Emergence of a novel human coronavirus threatening human health.  Nature Medicine, doi:10.1038/s41591-020-0796-5, https://doi.org/10.1038/s41591-020-0796-5 
  29. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS & Jamieson DJ. (2020). Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know.  American Journal of Obstetrics & Gynecology, doi:10.1016/j.ajog.2020.02.017, https://doi.org/10.1016/j.ajog.2020.02.017 
  30. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. (2020). Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.  The Lancet Infectious Diseases, doi:10.1016/S1473-3099(20)30086-4, https://doi.org/10.1016/S1473-3099(20)30086-4 
  31. Sun P, Qie S, Liu Z, Ren J, Li K & Xi J. (2020). Clinical characteristics of 50466 hospitalized patients with 2019-nCoV infection.  Journal of Medical Virology, doi:10.1002/jmv.25735, https://doi.org/10.1002/jmv.25735 
  32. Tanne JH. (2020). Covid-19: Trump says risk to Americans is "very low".  BMJ, 368, m793. doi:10.1136/bmj.m793, https://doi.org/10.1136/bmj.m793 
  33. Van Cuong L, Giang HTN, Linh LK, Shah J, Van Sy L, Hung TH, et al. (2020). The first Vietnamese case of COVID-19 acquired from China.  The Lancet Infectious Diseases, doi:10.1016/S1473-3099(20)30111-0, https://doi.org/10.1016/S1473-3099(20)30111-0 
  34. Wang M. (2020). 從抗新型冠狀病毒肺炎疫情看加強基層疾控能力的重要性 [The importance of strengthening the ability of fundamental disease prevention and control system from the perspective of the epidemic situation of COVID-19].  Chung-Hua Yu Fang i Hsueh Tsa Chih [Chinese Journal of Preventive Medicine], 54, E020. doi:10.3760/cma.j.cn112150-20200220-00149, https://doi.org/10.3760/cma.j.cn112150-20200220-00149 
  35. Wu F, Song Y, Zeng HY, Ye F, Rong WQ, Wang LM, et al. (2020).新型冠狀病毒肺炎疫情期間肝膽系統惡性腫瘤的診療策略探討  [Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of novel coronavirus pneumonia].  Chung-Hua Chung Liu Tsa Chih [Chinese Journal of Oncology], 42, E004. doi:10.3760/cma.j.cn112152-20200227-00137, https://doi.org/10.3760/cma.j.cn112152-20200227-00137 
  36. Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, et al. (2020). Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.  European Journal of Nuclear Medicine & Molecular Imaging, doi:10.1007/s00259-020-04735-9, https://doi.org/10.1007/s00259-020-04735-9 
  37. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.  The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(20)30079-5, https://doi.org/10.1016/S2213-2600(20)30079-5 
  38. Zeng Y & Zhen Y. (2020). Chinese medical staff request international medical assistance in fighting against COVID-19.  The Lancet Global Health, doi:10.1016/S2214-109X(20)30065-6, https://doi.org/10.1016/S2214-109X(20)30065-6 
  39. Zhai SL, Wei WK, Lv DH, Xu ZH, Chen QL, Sun MF, et al. (2020). Where did SARS-CoV-2 come from?.  Veterinary Record, 186, 254. doi:10.1136/vr.m740, https://doi.org/10.1136/vr.m740 (需訂閱)
  40. Zhang Q, Wang Y, Qi C, Shen L & Li J. (2020). Clinical trial analysis of 2019-nCoV therapy registered in China.  Journal of Medical Virology, doi:10.1002/jmv.25733, https://doi.org/10.1002/jmv.25733 

留言

張貼留言